Redefining HealthcareQualitest provides affordable, high-quality generic pharmaceuticals. Featuring a portfolio of over 600 products, the company is now ranked in the top ten among all suppliers of generics, based on total prescriptions filled. Qualitest is an operating company of Endo International plc, a global specialty healthcare company focused on improving patients’ lives while creating shareholder value. Learn more at www.endo.com.

DAVA Pharmaceuticals, Inc. is now part of Qualitest Pharmaceuticals, an Endo International plc company.• DAVA specializes in marketed, pre-launch and pipeline generic pharmaceuticals.
• DAVA Pharmaceuticals operates a generics franchise with a strategically-focused generics portfolio that includes a leadership position in the Methotrexate market.
• Addition of DAVA’s promising product pipeline across a broad range of therapeutic categories enhances the growth platform of our U.S. Generics business.
• As a natural fit to Endo’s U.S. Generics’ business (Qualitest), DAVA will be well-positioned to leverage Qualitest’s extensive relationships with the industry’s most important suppliers and customers, commercial expertise, and financial strength to execute its product launch strategy.

Boca Pharmacal is now part of Qualitest Pharmaceuticals, an Endo International plc company.• Boca Pharmacal is a specialty generics company with a unique generics product portfolio and complementary pipeline that builds on Qualitest’s strength in controlled substances.
• Addition of Boca Pharmacal’s product line and pipeline enhances the growth platform of our generic pharmaceuticals business-Qualitest.
• Transaction is consistent with Endo’s ongoing transformation into a specialty healthcare company.

Ranked 5th in the United States for Total Generic
Prescriptions Dispensed
(for the year ending June 2014).